Baidu
map

Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy

Zheng, Y; Deng, Z; Tang, MM; Cai, P

Cai, P (corresponding author), Hunan Prov Maternal & Child Hlth Care Hosp, Changsha 410008, Peoples R China.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, ; ():

Abstract

Background: Erythropoietin (EPO) plays a substantial role in cancer development and probably affects clinical outcomes. A functional polymorphism (rs1......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map